141 related articles for article (PubMed ID: 12787638)
1. Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid.
Jeong YI; Song JG; Kang SS; Ryu HH; Lee YH; Choi C; Shin BA; Kim KK; Ahn KY; Jung S
Int J Pharm; 2003 Jun; 259(1-2):79-91. PubMed ID: 12787638
[TBL] [Abstract][Full Text] [Related]
2. Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres.
Cirpanli Y; Unlü N; Caliş S; Hincal AA
J Microencapsul; 2005 Dec; 22(8):877-89. PubMed ID: 16423759
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Doolaanea AA
Drug Deliv Transl Res; 2016 Jun; 6(3):308-18. PubMed ID: 26817478
[TBL] [Abstract][Full Text] [Related]
4. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
5. Preparation of naltrexone hydrochloride loaded poly (DL-lactide-co-glycolide) microspheres and the effect of polyvinyl alcohol (PVA) as surfactant on the characteristics of the microspheres.
Suhaida MG; Yahya IB; Darmawati MY
Med J Malaysia; 2004 May; 59 Suppl B():63-4. PubMed ID: 15468820
[TBL] [Abstract][Full Text] [Related]
6. Poly (D,L-lactic-co-glycolide) nanoparticles for the improved therapeutic efficacy of all-trans-retinoic acid: a study of acute myeloid leukemia (AML) cell differentiation in vitro.
Simon AM; Jagadeeshan S; Abraham E; Akhilandeshwaran A; Pillai JJ; Kumar NA; Sivakumari AN; Kumar GS
Med Chem; 2012 Sep; 8(5):805-10. PubMed ID: 22741806
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of polymer based microcarriers for all-trans-retinoic acid.
Daşkın D; Gündüz U
Pharm Dev Technol; 2013; 18(5):1017-25. PubMed ID: 22428994
[TBL] [Abstract][Full Text] [Related]
8. Etanidazole-loaded microspheres fabricated by spray-drying different poly(lactide/glycolide) polymers: effects on microsphere properties.
Wang FJ; Wang CH
J Biomater Sci Polym Ed; 2003; 14(2):157-83. PubMed ID: 12661666
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of water-soluble drugs in PLGA microspheres.
Ito F; Fujimori H; Makino K
Colloids Surf B Biointerfaces; 2007 Feb; 54(2):173-8. PubMed ID: 17137764
[TBL] [Abstract][Full Text] [Related]
10. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
11. Effects of poloxamer 188 on the characteristics of poly(lactide-co-glycolide) nanoparticles.
Chae JM; Mo SM; Oh IJ
J Nanosci Nanotechnol; 2010 May; 10(5):3224-7. PubMed ID: 20358927
[TBL] [Abstract][Full Text] [Related]
12. Comparison of drug release from poly(lactide-co-glycolide) microspheres and novel fibre formulations.
Campbell CS; Delgado-Charro MB; Camus O; Perera S
J Biomater Appl; 2016 Mar; 30(8):1142-53. PubMed ID: 26620223
[TBL] [Abstract][Full Text] [Related]
13. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: characterization and drug release.
Blanco MD; Sastre RL; Teijón C; Olmo R; Teijón JM
J Microencapsul; 2005 Sep; 22(6):671-82. PubMed ID: 16401582
[TBL] [Abstract][Full Text] [Related]
15. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles.
Zuccari G; Carosio R; Fini A; Montaldo PG; Orienti I
J Control Release; 2005 Mar; 103(2):369-80. PubMed ID: 15763620
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of poly(vinyl alcohol) mediated prevention of aggregation and stabilization of insulin in nanoparticles.
Rawat S; Gupta P; Kumar A; Garg P; Suri CR; Sahoo DK
Mol Pharm; 2015 Apr; 12(4):1018-30. PubMed ID: 25644480
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles.
Shenderova A; Burke TG; Schwendeman SP
Pharm Res; 1997 Oct; 14(10):1406-14. PubMed ID: 9358554
[TBL] [Abstract][Full Text] [Related]
18. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
Song X; Song SK; Zhao P; Wei LM; Jiao HS
Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
[TBL] [Abstract][Full Text] [Related]
19. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
20. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
